Lion Point Capital’s Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant CPUH.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,492,054
Closed -$14.9M 44
2021
Q3
$14.9M Hold
1,492,054
2.8% 11
2021
Q2
$15.2M Hold
1,492,054
2.64% 11
2021
Q1
$15.1M Buy
+1,492,054
New +$15.7M 2.74% 11

Other funds holding CPUH.U

Lion Point Capital's CPUH.U Position: Q4 2021 in Review

Lion Point Capital sold out of Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant (CPUH.U) in Q4 2021, closing a stake of 1,492,054 shares — an estimated $14.9M sold.

Lion Point Capital first reported a position in CPUH.U in Q1 2021 and held it in 3 quarters. The position peaked at $15.2M in Q2 2021. 43 funds tracked by Wall St. Rank hold CPUH.U as of Q4 2021.

  • Lion Point Capital reported no remaining Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • Lion Point Capital sold 1,492,054 Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant shares in Q4 2021, an estimated $14.9M.
  • Lion Point Capital first reported a position in Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant in Q1 2021 and held it in 3 quarters.
  • Lion Point Capital's Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position peaked at $15.2M in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant as of Q4 2021.

Based on Lion Point Capital's 13F filing for Q4 2021, filed 14 Feb 2022.